Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Interim Results

25 Jan 2019 10:16

RNS Number : 1397O
Marechale Capital PLC
25 January 2019
 

25 January 2019

 

Marechale Capital plc

("Marechale Capital" or the "Company")

 

Interim Results

 

Marechale Capital plc today announces its unaudited interim results for the six months ended 31 October 2018.

 

Chairman's Statement

 

I report poor operating results for the first half which are broadly in line with the same period last year: revenues of £136,000 (2017: £125,000); and an operating loss of £(251,000) (2017 £(279,000)). The Company's net loss of £(184,000) (2017: £(460,000)) is after taking into account a gain of £67,000 on the realisation of one investment and in 2017, making a provision against the fair value of options held in investee companies of £119,000 and a provision for project loss in an associate of £63,000. Whilst our current deal flow remains strong, a number of the transactions we are involved in are taking longer to complete.

 

Marechale Capital is highly selective about the management teams, as well as the companies, it advises and backs with its investor relationships. On a more positive note this long-term strategy has resulted in 2018 being the Company's best year for exits with 5 multiple investor return exits and one write-off. Successful exits include the Sheen Falls Lodge, West Country Renewables and Inn Collection and more details on these, and the other transactions, can be found on our website.

 

The Board of Marechale Capital continues to consider its options and its future strategy.

 

 

Mark Warde-Norbury

Chairman

 

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Cenkos Securities

Azhic Basirov / David Jones

Tel: +44 (0)20 7397 8900

 

 

 

Consolidated Income Statement (unaudited)

 

 

6 months ended

 

 

 

 

31 October

31 October

 

 

 

 

 

2018

2017

 

 

 

 

 

£

£

Revenue

 

 

 

 

136,491

125,066

Cost of sales

 

 

 

 

(61,611)

(44,370)

 

 

 

 

 

 

 

Gross profit

 

 

 

 

74,880

80,696

 

 

 

 

 

 

 

Administrative expenses

 

 

 

(325,927)

(358,988)

 

 

 

 

 

 

 

Operating (loss)

 

 

 

(251,047)

(278,291)

 

 

 

 

 

 

 

Investment revenues

 

 

 

67,389

-

Other (losses)

Provision for project loss in associate

 

 

 

-

(118,5000)

(63,000)

 

 

 

 

 

 

 

(Loss) before tax

 

 

 

(183,658)

(459,791)

 

 

 

 

 

 

 

Taxation

 

 

 

 

-

-

 

 

 

 

 

 

 

(Loss) for the period

 

(183,658)

(459,791)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) per share

 

 

 

(Pence)

(Pence)

 

 

 

 

 

 

 

 

- Basic

 

(0.32)

(0.69)

 

- Diluted

 

 

 

(0.32)

(0.69)

 

 

 

 

 

 

 

 

 

Consolidated Balance Sheet (unaudited)

 

 

 

 

 

 

 

As at

 

 

 

 

31 October

31 October

 

 

 

 

 

 

2018

2017

 

 

 

 

 

 

£

£

 

Non current assets

 

 

 

 

 

 

Investment in associate

 

 

 

14,038

14,187

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Available for sale investments

 

 

107,087

153,341

 

Trading investments

 

 

 

78,388

78,388

 

Trade and other receivables

 

 

80,485

69,894

 

Cash and cash equivalents

 

 

63,172

98,110

 

 

 

 

 

 

329,132

399,734

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

 

343,170

413,921

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Trade and other payables

 

 

 

(117,107)

(125,596)

 

 

 

 

 

 

 

 

 

Total current liabilities

 

 

 

(117,107)

(125,596)

 

 

 

 

 

 

 

 

 

Net assets

 

 

 

 

226,063

288,325

 

 

Equity

 

 

 

 

 

 

 

Capital and reserves attributable to equity shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

Share capital

 

 

 

 

461,449

461,449

 

Revaluation reserve

 

 

 

25,826

81,826

 

Reserve for own shares

 

 

 

(50,254)

(50,254)

 

Retained losses

 

 

 

(210,958)

(289,150)

 

Reserve for share based payments

 

 

 

-

84,453

 

 

 

 

 

 

226,063

288,325

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Cash Flow Statement (unaudited)

 

 

 

 

 

 

6 months ended

31 October

31 October

 

 

 

 

 

2018

2017

 

 

 

 

 

£

£

Net cash from operating activities

 

 

 

 

Operating loss

 

(251,047)

(278,291)

 

 

 

 

 

 

 

Operating cash flows before movements in working capital

(251,047)

(278,291)

 

 

 

 

 

 

 

Movement in working capital

 

 

 

 

Decrease in receivables

 

 

120,689

151,781

(Decrease) in payables

 

 

(4,239)

(77,755)

 

 

 

 

 

 

 

 

 

 

 

 

116,450

74,026

 

 

 

 

 

 

Operating cash flow

 

 

 

(134,597)

(204,265)

 

 

 

 

 

 

 

Investment activities

 

 

 

 

 

Proceeds on disposal of available for sale investments

91,529

-

Expenditure on available for sale investments

Other

 

(12,700)

600

-

-

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

79,429

-

 

 

 

 

 

 

 

Financing

 

 

 

 

 

 

Issue of share capital

 

 

 

-

-

Interest payable

 

 

 

-

-

 

 

 

 

 

 

 

Cash flow from financing activities

 

-

-

 

 

 

 

 

 

 

Net decrease) in cash and cash equivalents

 

(55,168)

(204,265)

 

 

 

 

 

 

 

Cash and cash equivalents at start of the period

118,340

302,375

Cash and cash equivalents at end of the period

63,172

98,110

 

 

 

 

 

 

 

(Decrease) in cash and cash equivalents

 

(55,168)

(204,265)

 

 

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR CKPDKKBKDDDB
Date   Source Headline
8th Jun 20267:00 amPRNFCA Approves Stanford Capital Partners Change in Control
3rd Jun 20267:00 amPRNPosting of Circular and Notice of General Meeting
10th Apr 20261:00 pmPRNWeardale Lithium Receives £700k Grant
19th Jan 202612:15 pmPRNHalf-year Report
14th Oct 20254:00 pmPRNResult of AGM
14th Oct 20257:00 amPRNSubscription, Directors' Dealings, Related Party Transaction and Issue of Equity
16th Sep 20259:30 amPRNNotice of AGM
22nd Aug 20257:00 amPRNFinal Results
13th May 20257:00 amPRNIssue of Options to PDMR
19th Mar 20257:00 amPRNMarechale Advises on the Sale of Randalls
5th Feb 20251:30 pmPRNWeardale Lithium Planning Permission Application Update
29th Jan 202511:37 amPRNShare Price Movement
19th Dec 20244:30 pmPRNHalf-year Report
15th Oct 20242:30 pmPRNResult of AGM
20th Sep 20247:00 amPRNNotice of AGM
20th Aug 20247:00 amPRNFinal Results
6th Aug 20247:00 amPRNAppointment of Director
5th Dec 20237:00 amPRNHalf-year Report
22nd Nov 20231:00 pmPRNDirectorate Change
13th Oct 20233:51 pmPRNResult of AGM
19th Sep 20233:40 pmPRNNotice of AGM and Posting of Accounts
22nd Aug 20237:00 amPRNFinancial Statements for the Year Ended 30 April 2023
3rd Aug 202312:00 pmPRNHolding(s) in Company
28th Jun 20237:00 amPRNSubscription and Issue of Equity
2nd Mar 20227:00 amPRNPlacing, Subscription and Issue of Equity
1st Dec 20217:00 amPRNHalf-year Report
14th Oct 20213:28 pmRNSResult of AGM
11th Oct 20213:08 pmPRNHolding(s) in Company
8th Oct 20213:29 pmPRNHolding(s) in Company
5th Oct 20217:00 amPRNSubscription and Issue of Equity
22nd Sep 20212:57 pmPRNNotice of AGM
8th Sep 202111:54 amPRNHolding(s) in Company
7th Sep 20212:11 pmPRNDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSFinal Results
12th Mar 20219:32 amPRNHolding(s) in Company
5th Mar 20211:29 pmPRNHolding(s) in Company
5th Mar 20218:50 amPRNHolding(s) in Company
4th Mar 20213:24 pmPRNTrading Update
4th Mar 20219:19 amPRNHolding(s) in Company
23rd Feb 20215:00 pmPRNHolding(s) in Company
23rd Feb 20217:00 amPRNDirector/PDMR Shareholding
10th Feb 20212:27 pmPRNHolding(s) in Company
10th Feb 20217:00 amPRNHolding(s) in Company
4th Feb 20219:15 amPRNExercise of Options and Issue of Equity
3rd Feb 20217:00 amPRNStatement re Share Price Movement
2nd Feb 20216:20 pmPRNHolding(s) in Company
26th Jan 202111:47 amPRNPlacing, Subscription and Issue of Equity
11th Dec 202012:47 pmPRNGrant of Options to Directors
24th Nov 20207:00 amPRNHalf-year Report
26th Oct 20201:16 pmPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.